Nominated by: Gilead Sciences Organisation in nomination: Gilead Sciences Antiretroviral therapy (ART) has played an instrumental role in the treatment of HIV, increasing the life expectancy […]

Nominated by: DSM Organisation in nomination: DSM, Cargill Most people consume too many calories that originate from sugar, increasing the risk of being overweight or developing […]

Nominated by: Swiss Biotech Association Organisations in nomination: Rolf M Zinkernagel, Professor of Experimental Immunology at the University of Zurich    Viruses infect host cells and reproduce inside them. […]

Nominated by: DSM Organisation in nomination: DSM and Novozymes     Acrylamide can arise during the cooking process of foods via reaction of the amino acid asparagine and […]

Nominated by: Novartis Organisations in nomination: Novartis Gastroenteropancreatic neuroendocrine tumours are a rare type of cancer that can form in the pancreas or in other parts […]

Nominated by: Scienceindustries Switzerland  Organisation in nomination: Firmenich  Terpenes are complex natural compounds and important raw materials for the fragrance & flavour and the pharmaceutical industries. […]

Nominated by: BIO Deutschland Under the German Presidency of the Council of the European Union, 42 experts from academia and industry across 13 countries were invited […]

Nominated by: BIO Deutschland Organisation in nomination: AMSilk  Spider silk has long been hailed for its properties, the ultimate biomaterial, however production from spiders directly on […]

Nominated by: Voisin Consulting Life Sciences Launched in 1990, the Human Genome project was an unprecedented international scientific research project with the primary goal to discover […]

Nominated by: Voisin Consulting Life Sciences Organisation in nomination: European Commission  1996 saw the first legal/regulatory framework for medicinal products in the European Union. GONAL-f from […]

Nominated by: UK BioIndustry Association  Organisation in nomination: LifeArc    (From 2004) US Biotech company Organon’s scientists focused on the discovery of antibodies as therapeutics and […]

Nominated by: Federchimica Assobiotec Organisation in nomination: GlaxoSmithKline (GSK), currently moved to Orchard Therapeutics, Telethon Foundation (Telethon), l’IRCCS San Raffaele Hospital (SRH) Italy and Molecular Medicine SpA […]

Nominated by: Federchimica Assobiotec  Organisation in nomination: Government of Italy Early access programmes for novel medicines can benefit patients suffering from serious illnesses for which effective […]

Nominated by: UK BioIndustry Association  Organisation in nomination: Solexa: Professor Sir Shankar Balasubramanian and Professor Sir David Klenerman Following establishment of UK SME Solexa in 1997, Professor Sir […]

Nominated by: BIO Deutschland Organisations in nomination: BASF, Abbott, AbbVie, Cambridge Antibody Technology (now MedImmune) Diseases linked to the immune system, such as rheumatoid arthritis were very […]

Nominated by: Nominees: Dr Ingmar Hoerr, co-founder CureVac Professor Katalin Karikó, University of Pennsylvania and BioNTech The existence of mRNA was hypothesized early in the days […]

Nominated by: DSM, BASF    Organisation in nomination: DSM, BASF  Vitamin B2 (riboflavin), is a water-soluble compound, which can be synthesized by plants and microorganisms but […]

Nominated by: Sanofi Organisation in nomination: Sanofi Genzyme Fabry disease (also Anderson–Fabry) disease, is a rare and heritable genetic disorder. The genetic fault behind the disease […]